HDL and clinical and biochemical correlates in Italian non-smoker women

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 12, 2004, Pages 1408-1416

  Bigazzi, Federico ^a,b   Dal Pino, Beatrice ^a   Forastiere, Francesco ^c   Pistelli, Riccardo ^d   Rossi, Giuseppe ^a   Simoni, Marzia ^a   Baldacci, Sandra ^a   Viegi, Giovanni ^a   Bionda, Alberto ^b   Sampietro, Tiziana ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Regional Health Authority   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

Apolipoprotein A I; Coronary heart disease; Estrogens; High density lipoprotein; Hypoalphalipoproteinemia

Indexed keywords

ALCOHOL; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; ESTROGEN; HIGH DENSITY LIPOPROTEIN; LIPID; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BIOCHEMISTRY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION FUNCTION; ENVIRONMENTAL FACTOR; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; ITALY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; ALCOHOL DRINKING; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; APOLIPOPROTEINS B; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY DISEASE; ESTROGENS; FEMALE; HUMANS; ITALY; LIPIDS; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 19944426484     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.262     Document Type: Article

References (50)

1. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995;332:1758-66.
2. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barret-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association: writing group. Circulation 1997; 96:2468-82.
3. 8 Health and Stroke Facts: Statistical Update. Dallas, Texas: American Heart Association, 1998.
4. Fiebach NH, Viscoli CM, Horwitz R. Differences between women and men in survival after myocardial infarction: biology or methodology? J Am Med Assoc 1990; 263:1092-6.
5. Malacrida R, Genoni M, Maggioni AP, Spataro V, Parish S, Palmer A, et al. A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N Engl J Med 1998;338:8-14.
6. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. The National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999;341:217-25.
7. Mitchell BD, Hazuda HP, Haffner SM, Patterson JK, Stern MP. Myocardial infarction in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Circulation 1991;83:45-51.
8. Aguilar-Salinas CA, Olaiz G, Valles V, Rios Torres JM, Gómez Pérez FJ, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res 2001;42:1298-307.
9. Gordon T, Castelli WP, Hjortland MC, Kannel TR, Dawber TR. High density lipoprotein as a protective factor against coronary artery disease: the Framingham study. Am J Med 1977;62:707-14.
10. Gordon D, Rifkind BM. Current concepts: high density lipoproteins: the clinical implications of recent studies. N Engl J Med 1989;321:1311-5.
11. Assmann G, Schulte H. Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease. Am J Cardiol 1992;70:733-7.
12. Miller NE, Forde OH, Thelle DS, Mjos OD. The Tromso Heart Study: high density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1977;1:965-70.
13. Keys A. Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death. Lancet 1980;2:603-6.
14. Jacobs DR. High density lipoprotein cholesterol and coronary heart disease, cardiovascular disease, and all-cause mortality. Circulation 1985;72(Suppl III):III-85.
15. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein levels: the Framingham study. J Am Med Assoc 1986;256:2835-8.
16. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High density lipoprotein cholesterol and cardiovascular disease. Circulation 1989;79:8-15.
17. Whayne TF, Alaupovic P, Curry MD, Lee ET, Anderson PS, Schechter E. Plasma apolipoprotein B and VLDL-, and LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis 1981;39:411-24.
18. The Expert Panel. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J Am Med Assoc 1993;269:3015-23.
19. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-95.
20. Hunt SC, Hasstedt SJ, Kuida H, Stults BM, Hopkins PN, Wiliams RR. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigree and twins. Am J Epidemiol 1989;129:625-8.
21. Moti L, Kashyap MD. Mechanistic studies of high density lipoprotein. Am J Cardiol 1998;82:42U-48U.
22. Third JL, Montag J, Flynn M, Freidel J, Laskarzewski P, Glueck CJ. Primary and familial hypoalphalipoproteinemia. Metabolism 1984;33:136-46.
23. Schaeffer EJ, Heaton WH, Wetzel MG. Plasma apolipoprotein A-I absence associated with a marked reduction of high density lipoprotein and premature coronary artery disease. Arteriosclerosis 1982;2:16-26.
24. Genest JJ, Mertin SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992;85:2025-33.
25. Vergani C, Bettale G. Familial hypoalphalipoproteinemia. Clin Chim Acta 1981;114:42-52.
26. Glueck CJ, Fallat RW, Millett F, Gartiside P, Elston RC, Go RC. Familial hyper-alpha-lipoproteinemia: studies in eighteen kindreds. Metabolism 1975;24:1243-65.
27. SA-Ito F. A pedigree of homozygous familial hyperalphalipoproteinemia. Metabolism 1984;33:629-33.
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;309:1087.
29. Kannel, WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, et al, for the MRFIT Research Group. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Am Heart J 1986;112:825-36.
30. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mantteri M, Heinonen OP, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 1992;85:37-45.
31. Menotti A, Seccarecchia F, Lanti MP. Mean levels and distributions of some cardiovascular risk factors in Italy in the 1970s and the 1980s. The Italian RIFLE pooling project risk factors and life expectancy. G Ital Cardiol 1995;25:1539-72.
32. Barter P. High density lipoproteins and reverse cholesterol transport. Curr Opin Lipidol 1993;4:210-7.
33. Rader DJ, Schaefer JR, Lohse P, Katsunori I, Fairwell T, William AH, et al. Increased production of apolipoprotein A-I associated with elevated plasma levels of high density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia. Metabolism 1993;42:1429-34.
34. Schaefer EJ, Lamon-Fava S, Ordovas JM. Factors associated to low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-1 levels in the Framingham offspring study. J Lipid Res 1994; 35:871-82.
35. Anderson AJ, Sobocinski KA, Freedman DS, Barboriak JJ, Rimm AA, Gruchow HW. Body fat distribution, plasma lipids, and lipoproteins. Arteriosclerosis 1988; 8:88-94.
36. Ghiselli G, Beigel Y, Gotto AM. Apolipoprotein A-I and A-II metabolism in subjects with coronary heart disease (CHD). In: Human Apolipoprotein Mutants. New York: Plenum, 1986; 133-8.
37. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, et al. Human apolipoprotein A-I and A-II metabolism. J Lipid Res 1982;23:850-62.
38. Roma P, Gregg RE, Bishop C, Ronan R, Zech LA, Meng MV, et al. Apolipoprotein A-I metabolism in subjects with a Pstl restriction fragment length polymorphism of the apoA-I gene and familial hypoalphalipoproteinemia. J Lipid Res 1990;31:1753-60.
39. Le NA, Ginsberg HN. Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol. Metabolism 1988;3337:614-7.
40. Rader DJ, Ikewaki K, Duverger N, Feuerstein I, Zech L, Connor H, et al. Very low high-density lipoproteins without coronary atherosclerosis. Lancet 1993;342:1455-8.
41. Lamarche B, Després JP, Pouliot MC, Prud'homme D, Morjani S, Lupien PJ, et al. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb 1993;13:33-40.
42. Trémollières FA, Pouilles JM, Cauneille C, Ribot C. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis 1999;142:415-3.
43. De Aloysio D, Gambacciani M, Meschia M, Pansini F, Bacchi A, Bolis P, et al. The Icarus Study Group. The effect of menopause on blood lipid and lipoprotein levels. Atherosclerosis 1999;147:147-53.
44. Pao-Ling T, Ta-Chen S, Fung C, Kuo-Liong C, Su-Cheng H, Song-Nan C, et al. Effects of menopause and obesity on lipid profiles in middle-aged Taiwanese women: the Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2000;153:413-21.
45. De Oliveira E, Foster D, Harper M, Seidman CE, Smith JD, Breslow JL, et al. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 2000;102:2347-52.
46. Goldberg CS, Tall AR, Krumholz S. Acute inhibition of hepatic lipase and increase in plasma lipoproteins after alcohol intake. J Lipid Res 1984;25:714-20.
47. Valimaki ME, Nikkila EA, Askinen MR, Ylikahri R. Rapid decrease in high density lipoprotein subfractions and postheparin plasma lipase activities after cessation of chronic alcohol intake. Atherosclerosis 1986;59:147-53.
48. Savolainen MJ, Hannuksela M, Seppanen S, Kervinen K, Kesaniemi YA. Increase in high density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Eur J Clin Invest 1990;20:593-9.
49. Granfone A, Campos H, McNamara JR, Schaefer MM, Lamon-Fava S, Ordovas JM, et al. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. Metabolism 1992;41:1193-8.
50. Seishima MC, Bisgaier L, Davies SL, Glickman RM. Regulation of hepatic apolipoprotein synthesis in the 17-α-ethinyl estradiol-treated rat. J Lipid Res 1991;32:941-51.